Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma
| Status: | Archived |
|---|---|
| Conditions: | Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2009 |
| End Date: | January 2012 |
Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma: A Phase I Trial
This is a phase I, prospective, open label, dose escalation study of azacitidine in
combination with rituximab, vincristine, and cyclophosphamide for the treatment of
refractory lymphoma. The investigators expect to enroll 12-24 patients in this trial over a
2 year accrual period.
We found this trial at
1
site
Click here to add this to my saved trials
